Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2017 Nov;96(47):e8903.
doi: 10.1097/MD.0000000000008903.

Case report: remarkable remission of SAPHO syndrome in response to Tripterygium wilfordii hook f treatment

Chen Li  1 , Xiaochuan Sun, Yihan Cao, Wenrui Xu, Wen Zhang, Zhenhua Dong
Affiliations
Case Reports

Case report: remarkable remission of SAPHO syndrome in response to Tripterygium wilfordii hook f treatment

Chen Li et al. Medicine (Baltimore). 2017 Nov.

Abstract

Rationale: SAPHO (synovitis, acne, pustulosis, hyperostosis, and osteitis) syndrome is an autoinflammatory disease with no standardized treatment. Tripterygium wilfordii hook f (TwHF) is a Chinese herb with immunosuppressive effects and has been used to treat some chronic inflammatory diseases. However, it has not been reported as a therapeutic option in SAPHO syndrome. Here we present the first report in which a remarkable remission of SAPHO syndrome was achieved in response to TwHF.

Patient concerns: A 57-year-old female patient noted swelling and pain at the anterior chest wall and scattered rashes like psoriasis vulgaris. Bone scintigraphy demonstrated the classic "bull's head" sign and magnetic resonance images indicated bone marrow edema on T5.

Diagnoses: The diagnosis was made by dermatological and osteoarticular manifestations and classical "bull's head" sign in bone scintigraphy.

Interventions: TwHF with a priming dose of 20 mg 3 times per day and a gradual dose reduction of 20 mg per day in every 3 months. Four months later, methotrexate was added with 10 mg per week.

Outcomes: Osteoarticular symptoms and radiological abnormalities were improved dramatically.

Lessons: This case illustrates a promising strategy to treat SAPHO syndrome.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

Figure 1
Figure 1
Imaging examination results. (A) 99mTc bone scintigraphy demonstrated the classic “bull's head” sign in the anterior chest wall (while circle). (B) MR image (Fat-suppression T2WI sequence) obtained before TwHF treatment revealed high signal intensity in T5 (white arrow), corresponding to bone marrow edema. (C) Bone marrow edema disappeared (white arrow) 4 months after the administration of TwHF.
Figure 2
Figure 2
Decrease of inflammatory condition parameters and disease activity indexes after administration of TwHF. Methotrexate (MTX) was added after 4-month treatment of TwHF (black arrow).
See this image and copyright information in PMC

References

    1. Firinu D, Garcia-Larsen V, Manconi PE, et al. SAPHO syndrome: current developments and approaches to clinical treatment. Curr Rheumatol Rep 2016;18:35. - PubMed
    1. Kao PN, Qiu D. Immunosuppressive and anti-inflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii Hook. f. Drugs R D 2003;4:1–8. - PubMed
    1. Benhamou CL, Chamot AM, Kahn MF, et al. Synovitis-acne-pustulosis hyperostosis-osteomyelitis syndrome (SAPHO). A new syndrome among the spondyloarthropathies? Clin Exp Rheumatol 1988;6:109–12. - PubMed
    1. Wong KF, Yuan Y, Luk JM. Tripterygium wilfordii bioactive compounds as anticancer and anti-inflammatory agents. Clin Exp Pharmacol Physiol 2012;39:311–20. - PubMed
    1. Lawrence T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol 2009;1:a001651. - PMC - PubMed

Publication types

Substances